Evidence Synthesis
Nureca Limited (NURECA) experienced a significant shift in its financial performance, with key metrics indicating a notable acceleration in its quarterly earnings.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 3 Sept 2026, 03:29
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Nureca Limited (NURECA) experienced a significant shift in its financial performance, with key metrics indicating a notable acceleration in its quarterly earnings.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 37.75 % | 7.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.15 % | 2.83 | ▲ |
| REVENUE_GROWTH_YOY | 18 % | 296.3 | ▼ |
| PRICE_CHANGE_PERCENT | -0.664 % | — | - |
| DAILY_VOLUME | 1,655 shares | 35,378 | ▼ |
| CLOSE_PRICE | 336.75 INR | 339 | ▼ |